Tiffany L. Fallaw, BS, RVT
Department of Small Animal Medicine and Surgery
College of Veterinary Medicine
University of Georgia
Athens, GA 30602
|
Pimobendan treatment in dogs with congestive heart failure
November 1, 2007
By:
Justin D. Thomason, DVM, DACVIM (small animal internal medicine)
,
Tiffany L. Fallaw, BS, RVT
,
Clay A. Calvert, DVM, DACVIM (small animal internal medicine)
Editors' note: This article is an updated excerpt from "Pimobendan: Understanding its cardiac effects in dogs with myocardial disease," which appeared in Veterinary Medicine's October 2006 issue.
|
Pimobendan: Understanding its cardiac effects in dogs with myocardial disease
October 1, 2006
By:
Justin D. Thomason, DVM, DACVIM (small animal internal medicine)
,
Tiffany L. Fallaw, BS, RVT
,
Clay A. Calvert, DVM, DACVIM (small animal internal medicine)
Pimobendan, a benzimidazole-pyridazinone drug, is classified as an inodilator because of its nonsympathomimetic, nonglycoside positive inotropic (through myocardial calcium sensitization) and vasodilator properties.
|
|